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This article contains raw and processed data related to research
published in “Quantitative Proteomic Proﬁling Reveals Hepatic
Lipogenesis and Liver X Receptor Activation in the PANDER
Transgenic Model” (M.G. Athanason, W.A. Ratliff, D. Chaput, C.B.
MarElia, M.N. Kuehl, S.M., Jr. Stevens, B.R. Burkhardt (2016)) [1],
and was generated by “spike-in” SILAC-based proteomic analysis
of livers obtained from the PANcreatic-Derived factor (PANDER)
transgenic mouse (PANTG) under various metabolic conditions
[1]. The mass spectrometry output of the PANTG and wild-type
B6SJLF mice liver tissue and resulting proteome search from
MaxQuant 1.2.2.5 employing the Andromeda search algorithm
against the UniprotKB reference database for Mus musculus has
been deposited to the ProteomeXchange Consortium (http://
www.proteomexchange.org) via the PRIDE partner repository
with dataset identiﬁers PRIDE: PXD004171 and http://dx.doi.org/
10.6019/PXD004171. Protein ratio values representing PANTG/
wild-type obtained by MaxQuant analysis were input into the
Perseus processing suite to determine statistical signiﬁcance
using the Signiﬁcance A outlier test (po0.05). Differentially
expressed proteins using this approach were input into Ingenuity
Pathway Analysis to determined altered pathways and upstream
regulators that were altered in PANTG mice.
& 2016 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).vier Inc. This is an open access article under the CC BY license
/j.mce.2016.07.009
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ow data was
acquiredPre-fractionated samples analyzed by LC-MS/MS. Tryptic peptides were sepa-
rated on a 10 cm x 75 cm I.D. reversed phase column packed with 5 μm C18
material with 300 Å pore size (New Objective) using 125 min gradients of 2–40%
ACN in 0.1% formic acid and mass spectrometric analysis performed inline on an
Orbitrap XL.ata format Raw and analyzed
xperimental
factorsPANcreatic-DERived factor (PANDER) transgenic and wild-type mice were
treated under three metabolic conditions: fasted, fed and insulin stimulated.
Protein lysate was obtained from liver tissue that was snap-frozen in liquid
nitrogen immediately after excision following treatment and euthanasia. Tryptic
peptides were generated utilizing the FASP method. Following a desalt proce-
dure, peptides were fractionated by SCX chromatography.xperimental
featuresMass spectrometry output was obtained utilizing LC-MS/MS. Survey scans were
performed at a resolving power of 60,000 and the top 10 most abundant peaks
were selected for subsequent MS/MS analysis.ata source
locationCell Biology, Microbiology and Molecular Biology, CDDI Proteomics Facility.
University of South Florida, Tampa, Florida, United States.ata accessibility Data available within this article and through the ProteomeXchange Consortium
via the PRIDE partner repository with dataset identiﬁers PRIDE: PXD004171:
Proteomic Evaluation of PANDER TG Mice, Project http://dx.doi.org/10.6019/
PXD004171, Username: reviewer56976@ebi.ac.uk, Password: VtR5rnIRValue of the data
 This is the ﬁrst dataset to detail global proteome changes in the liver of the PANDER transgenic
mouse model, a disease model of selective hepatic insulin resistance and metabolic disease.
 Biological analysis demonstrated a pleiotropic impact on a variety of functions such as lipid
metabolism and numerous cellular functions such as growth, proliferation, death, and signaling.
 This dataset provides a valuable proteomic resource for further metabolic data mining examining
PANDER-induced biological functions1. Data
SILAC-based proteomic analysis was performed on isolated murine liver tissue following various
metabolic treatments obtained from the PANDER transgenic mouse. Of which, 3304 hepatic proteins
were identiﬁed with analysis comparing PANTG versus wild-type hepatic proteomes within a speciﬁc
metabolic condition. Of those, there were 228, 239 and 189 differentially expressed proteins in the
fasted, fed and insulin-stimulated conditions within the PANTG liver as compared to WT, respectively,
as determined by the Signiﬁcance A outlier test in Perseus (po0.05, n¼3, combined prior to outlier
test). All differentially expressed proteins are listed in Supplementary Tables 1–3 with overall Venn-
Diagram of comprehensive results in Fig. 1. A modiﬁed ProteinGroups ﬁle from MaxQuant showing
ratio values for all proteins in each biological replicate along with corresponding RSD values is
uploaded in PRIDE under the same accession number.
Fig. 1. Identiﬁcation of unique proteins across metabolic states in PANTG. SILAC spike in fractionated protein extracts were
analyzed by LC-MS/MS from age- and gender-matched wild-type and PANTG mice (n¼3 per metabolic condition and geno-
type). Approximately 3300 proteins were conﬁdently revealed that were shared across genotype and metabolic conditions with
overlap indicated in Venn diagram.
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2.1. PANTG murine model
The proteomic analysis performed in this study utilized the transgenic overexpressing model of
PANDER. As previously detailed, this model displays increased circulating levels of PANDER produced
from the endocrine pancreas [2].
2.2. Metabolic procedures of PANTG
To examine the PANDER-induced hepatic proteome under various metabolic conditions, the
PANTG model was exposed to fasting, fed and insulin-stimulated states as detailed in prior manu-
script [1].
2.3. Liver sample preparation for proteomic analysis
Approximately 40 mg of tissue was excised from a lobe of mouse liver for tissue lysis. Tissue was
submerged in cold lysis buffer (100 mM Tris–HCl, 100 mM DTT, 4% SDS and 1xHALT protease inhi-
bitor) and lysed using a Qiagen TissueRupter. Cell lysate was then heated at 95 °C for ﬁve minutes
followed by brief sonication. The tissue lysate was cleared by centrifugation at 16,000 g for 5 min
and the supernatant was collected and stored at 80 °C prior to further analysis. The same procedure
for protein puriﬁcation was performed on the “heavy” labeled (13C6 L-Lysine) liver (Cambridge Isotope
Laboratories, Inc).
Protein concentration was quantiﬁed using the Pierce 660 nm protein assay kit supplemented
with the provided ionic detergent compatibility reagent (IDCR). Equal mass of labeled and unlabeled
protein or “light” and “heavy” protein respectively, were combined and digested using the ﬁlter-aided
sample preparation (FASP) method (Expedeon). Samples were desalted as previously described [1].
Peptides were fractionated by strong cation exchange chromatography as previously described [3].
2.4. LC-MS/MS, data processing and pathway analysis
Fractions were separated on a 10 cm75 μm I.D. reversed phase column packed with 5 μm C18
material with 300 Å pore size (New Objective) using 120 min gradients of 2–40% ACN in 0.1% formic
acid. Inline mass spectrometric analysis was performed on a hybrid linear ion trap-Orbitrap mass
spectrometer (Orbitrap XL (Thermo Fisher Scientiﬁc). Full MS survey scans were performed at a
resolving power of 60,000, and the top 10 most abundant peaks were selected for subsequent MS/MS
analysis in the linear ion trap. Raw ﬁles were processed in MaxQuant 1.2.2.5 employing the Andro-
meda search algorithm and searched against the UniprotKB reference database for Mus musculus,
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with the MaxQuant suite was also employed. All fractions for each biological sample were combined
for analysis. Constant modiﬁcation of carbamidomethylation of cysteine and variable modiﬁcations of
oxidized methionine and acetylated protein N-termini were used. Additionally, Lys-6 for the spike-in
internal standard was set as a label in the group-speciﬁc parameter section. A false discovery rate of
1% was used for peptides and proteins. A minimum peptide length of 6 amino acids was used. Razor
and unique peptides were used for identiﬁcation and quantiﬁcation. Protein ratio values were
reconstructed using median peptide ratio values across all three biological replicates for each
experimental group where the ﬁnal ratio for each protein was calculated by determining the ratio-of-
ratio (PANTG/Internal Standard)/(WT/Internal Standard). Final ratios were input into the Perseus
processing suite (Perseus version 1.2.0.13). Statistical analysis was performed using the Signiﬁcance A
outlier test where statistical signiﬁcance based on magnitude fold-change was established at po0.05.
Ratio values and Uniprot Protein identiﬁcation numbers of differentially expressed proteins were
uploaded to Ingenuity Pathway Analysis (IPA). Total number of unique proteins identiﬁed within and
across metabolic states within the PANTG and WT mice are shown in Fig. 1. Complete listings of all
differentially expressed proteins within the PANTG liver as compared to WT identiﬁed under the
metabolic conditions of fasting, fed, and insulin-stimulated are shown (Supplementary Tables 1–3).In
addition, a modiﬁed ProteinGroups ﬁle from MaxQuant showing protein ratios generated for each
biological replicate and with quantiﬁable relative standard deviation values is also listed (Supple-
mentary Tables 4).Acknowledgments
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